Literature DB >> 16170049

Virtual ligand screening against Escherichia coli dihydrofolate reductase: improving docking enrichment using physics-based methods.

Katarzyna Bernacki1, Chakrapani Kalyanaraman, Matthew P Jacobson.   

Abstract

Motivated by their participation in the McMaster Data-Mining and Docking Competition, the authors developed 2 new computational technologies and applied them to docking against Escherichia coli dihydrofolate reductase: a receptor preparation procedure that incorporates rotamer optimization of side chains and a physics-based rescoring procedure for estimating relative binding affinities of the protein-ligand complexes. Both methods use the same energy function, consisting of the all-atom OPLS-AA force field and a generalized Born solvent model, which treats the protein receptor and small-molecule ligands in a consistent manner. Thus, the energy function is similar to that used in more sophisticated approaches, such as free-energy perturbation and the molecular mechanics Poisson-Boltzmann/surface area, but sampling during the rescoring procedure is limited to simple energy minimization of the ligand. The use of a highly efficient minimization algorithm permitted the authors to apply this rescoring procedure to hundreds of thousands of protein-ligand complexes during the competition, using a modest Linux cluster. To test these methods, they used the 12 competitive inhibitors identified in the training set, plus methotrexate, as positive controls in enrichment studies with both the training and test sets, each containing 50,000 compounds. The key conclusion is that combining the receptor preparation and rescoring methods makes it possible to identify most of the positive controls within the top few tenths of a percent of the rank-ordered training and test set libraries.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16170049     DOI: 10.1177/1087057105281220

Source DB:  PubMed          Journal:  J Biomol Screen        ISSN: 1087-0571


  6 in total

1.  Search for non-nucleoside inhibitors of HIV-1 reverse transcriptase using chemical similarity, molecular docking, and MM-GB/SA scoring.

Authors:  Gabriela Barreiro; Cristiano R W Guimarães; Ivan Tubert-Brohman; Theresa M Lyons; Julian Tirado-Rives; William L Jorgensen
Journal:  J Chem Inf Model       Date:  2007-10-20       Impact factor: 4.956

2.  Molecular modelling and competition binding study of Br-noscapine and colchicine provide insight into noscapinoid-tubulin binding site.

Authors:  Pradeep K Naik; Seneha Santoshi; Ankit Rai; Harish C Joshi
Journal:  J Mol Graph Model       Date:  2011-04-09       Impact factor: 2.518

3.  Life beyond kinases: structure-based discovery of sorafenib as nanomolar antagonist of 5-HT receptors.

Authors:  Xingyu Lin; Xi-Ping Huang; Gang Chen; Ryan Whaley; Shiming Peng; Yanli Wang; Guoliang Zhang; Simon X Wang; Shaohui Wang; Bryan L Roth; Niu Huang
Journal:  J Med Chem       Date:  2012-06-19       Impact factor: 7.446

4.  Representation of target-bound drugs by computed conformers: implications for conformational libraries.

Authors:  Stefan Günther; Christian Senger; Elke Michalsky; Andrean Goede; Robert Preissner
Journal:  BMC Bioinformatics       Date:  2006-06-09       Impact factor: 3.169

Review 5.  Virtual ligand screening: strategies, perspectives and limitations.

Authors:  Gerhard Klebe
Journal:  Drug Discov Today       Date:  2006-07       Impact factor: 7.851

6.  Molecular modeling and prediction of binding mode and relative binding affinity of Art-Qui-OH with P. falciparum Histo-Aspartic Protease (HAP).

Authors:  Rajani Kanta Mahapatra; Niranjan Behera; Pradeep Kumar Naik
Journal:  Bioinformation       Date:  2012-09-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.